• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Hematuria Treatment Companies

    ID: MRFR/MED/1200-HCR
    85 Pages
    Kinjoll Dey
    October 2025

    Hematuria, the presence of blood in the urine, can be a symptom of various underlying conditions, including infections, kidney stones, and urinary tract disorders. Treatment approaches for hematuria depend on the underlying cause. Companies involved in the development and provision of treatments for conditions related to hematuria may include pharmaceutical, medical device, and diagnostic companies. It's important to note that the treatment of hematuria involves addressing the specific cause of the bleeding.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hematuria Treatment Market Research Report -Forecast to 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Hematuria Treatment Market

    hematuria treatment Key Companies

     

    Latest Hematuria Treatment Companies Update

     


    Roche Holding AG Received FDA approval for their Elevate® AI-powered platform to analyze urinary sediments and help diagnose microscopic hematuria, potentially leading to earlier detection and intervention.Collaborated with healthcare providers to implement their Prematurity Prediction Model for identifying patients at risk of preterm birth, which can involve microscopic hematuria in some cases.


    Philips Healthcare Introduced their Lumify™ System with new point-of-care ultrasound probes specifically designed for rapid and accurate assessment of renal structures and potential causes of hematuria.Partnered with medical institutions to improve access to their diagnostic tools and support early evaluation of suspected hematuria cases.


    Boston Scientific Corporation Launched their LithoVue™ Flexible Ureteroscope with enhanced visualization capabilities for minimally invasive diagnosis and treatment of kidney stones, a common cause of gross hematuria.Focused on developing robotic and AI-assisted surgical technologies for urological procedures related to hematuria treatment.


    Beckman Coulter Introduced their AU680 Flow Cytometer with advanced automation and cell differentiation capabilities, improving accuracy in identifying abnormal urinary cells associated with certain types of hematuria.Collaborated with laboratories to expand access to their diagnostic tools and streamline hematuria evaluation workflows.


    Alnylam Pharmaceuticals Announced promising results from Phase 2 clinical trials of their RNAi therapeutic candidate for the treatment of anti-glomerular basement membrane (anti-GBM) disease, a rare cause of severe hematuria.Continued research on developing novel targeted therapies for specific causes of hematuria offering potential for improved treatment outcomes.


    List of hematuria treatment Key Companies in the Market




    • AstraZeneca Plc




    • Bristol-Myers Squibb




    • F. Hoffmann-La Roche Ltd.




    • GlaxoSmithKline Inc.




    • Janssen Pharmaceuticals Inc.




    • Merck & Co.




    • Novartis International AG




    • Pfizer Inc.




    • Sun Pharmaceutical Industries Limited




    • The Medicines Company